drugset / Trial / NCT00513357

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

NCT00513357

Phase 3 Completed 82 enrolled M.D. Anderson Cancer Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this clinical research study is to evaluate the effectiveness of melatonin for the management of poor appetite and weight loss in advanced cancer patients. The effectiveness of melatonin on weight gain, keeping/gaining of lean muscle mass, improved appetite, and side effects will also be evaluated.

Timeline

Start
2006-06
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 20 mg Oral